TARGETING EPIGENETIC ABERRATIONS IN CHEMORESISTANT OVARIAN TUMORS

$382,849FY2014Department of the ArmyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →

TARGETING EPIGENETIC ABERRATIONS IN CHEMORESISTANT OVARIAN TUMORS · GrantIndex